Transatlantic taskforce perspectives on phage therapy

The transatlantic taskforce on antimicrobial resistance sets out research and regulatory priorities for phage therapy, including standardized susceptibility testing, experimental models, GMP and personalized-treatment criteria, and clearer routes to patient access.